No Data
CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm
Express News | FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older
BofA Securities Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $32
CCORF Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $33
William Blair Maintains Ceribell(CBLL.US) With Buy Rating
Top Midday Gainers
